New patent for Genus Lifesciences drug LEVOLET

January 11, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for LEVOLET Levolet is a drug marketed by Genus Lifesciences and is included in one NDA. The generic ingredient in LEVOLET is levothyroxine sodium. Additional details…

The post New patent for Genus Lifesciences drug LEVOLET appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.